Sarepta Therapeutics
SRPT
#4401
Rank
ยฃ1.75 B
Marketcap
ยฃ16.71
Share price
-2.45%
Change (1 day)
-83.12%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ0.99 Billion

According to Sarepta Therapeutics 's latest financial reports the company has ยฃ0.99 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sarepta Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ1.21 B80.49%
2023-12-31$ยฃ0.67 B111.98%
2022-12-31$ยฃ0.31 B-53.72%
2021-12-31$ยฃ0.68 B23.02%
2020-12-31$ยฃ0.55 B-10.43%
2019-12-31$ยฃ0.62 B-23.27%
2018-12-31$ยฃ0.81 B39.26%
2017-12-31$ยฃ0.58 B114.01%
2016-12-31$ยฃ0.27 B112.44%
2015-12-31$ยฃ0.12 B-19.25%
2014-12-31$ยฃ0.15 B6.15%
2013-12-31$ยฃ0.14 B95.84%
2012-12-31$ยฃ76.52 M283.45%
2011-12-31$ยฃ19.95 M-1193.57%
2010-12-31$-ยฃ1.83 Million-112.5%
2009-12-31$ยฃ14.6 M36.04%
2008-12-31$ยฃ10.73 M-19.17%
2007-12-31$ยฃ13.27 M-31.03%
2006-12-31$ยฃ19.25 M-38.13%
2005-12-31$ยฃ31.11 M127.41%
2004-12-31$ยฃ13.68 M-43.59%
2003-12-31$ยฃ24.25 M65.65%
2002-12-31$ยฃ14.64 M-30.46%
2001-12-31$ยฃ21.05 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
ยฃ16.10 B 1,525.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-ยฃ0.12 Billion-111.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
ยฃ1.41 B 42.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ0.3 Billion-129.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.17 B-82.28%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-ยฃ0.12 Billion-111.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
ยฃ0.70 B-28.37%๐Ÿ‡บ๐Ÿ‡ธ USA